A new bill before Congress would move cannabis from its Schedule I designation to Schedule III, the same classification shared by tylenol codeine, ketamine and dronabinol.
Congressmen Rep. Matt Gaetz...
The Justice Department under Attorney General Jeff Sessions blocked the Drug Enforcement Administration (DEA) from taking action on two dozen requests to grow cannabis for research.
The DEA began accepting...
FDA officials put out a call for comments in Monday’s Federal Register, seeking information about cannabidiol (CBD) and how the United Nation’s World Health Organization should designate it as a substance....
The U.S. Drug Enforcement Administration (DEA) intends to decrease the amount of cannabis it allocates for federally approved research.
The DEA has released its proposed 2018 aggregate production...
As the legal cannabis industry booms in Colorado, residential cultivators around the state are leaving behind large amounts of mold and extensive property damage.
Denver detective Brian Matos estimates...
